Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
KROS
Keros Therapeutics
Last Price:
$16.76
Seasonality Move:
16.43%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.65 | Sell |
20-day SMA: | 42.84 | Sell |
50-day SMA: | 53.27 | Sell |
200-day SMA: | 53.34 | Sell |
8-day EMA: | 22.31 | Sell |
20-day EMA: | 35.87 | Sell |
50-day EMA: | 47.32 | Sell |
200-day EMA: | 51.22 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.01 | Sell |
Relative Strength Index (14 RSI): | 22.54 | Sell |
Chaikin Money Flow: | -255136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.12 - 66.36) | Sell |
Bollinger Bands (100): | (39.95 - 65.57) | Sell |
Keros Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.71 while KROS 8-day simple moving average is 17.65, which is a Sell signal.
-
The stock price of KROS is 16.71 while Keros Therapeutics 20-day SMA is 42.84, which makes it a Sell.
-
Keros Therapeutics 50-day simple moving average is 53.27 while KROS share price is 16.71, making it a Sell technically.
-
KROS stock price is 16.71 and Keros Therapeutics 200-day simple moving average is 53.34, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
10
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $16.71. The Score for KROS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
676.9M
Price in USD:
16.71
Share Volume:
378.8K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
15.67
Sell
10
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 16.71 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.71 while KROS 8-day exponential moving average is 22.31, which is a Sell signal.
-
The stock price of KROS is 16.71 while Keros Therapeutics 20-day EMA is 35.87, which makes it a Sell.
-
Keros Therapeutics 50-day exponential moving average is 47.32 while KROS share price is 16.71, making it a Sell technically.
-
KROS stock price is 16.71 and Keros Therapeutics 200-day simple moving average is 51.22, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $0.36 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -12.01, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 22.54, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is (24.12 - 66.36), which suggest Keros Therapeutics is a Sell
-
The Bollinger Bands (100) for Keros Therapeutics is (39.95 - 65.57), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.